48 results
8-K
CERE
Cerevel Therapeutics Holdings Inc
16 Feb 24
Submission of Matters to a Vote of Security Holders
4:46pm
to retain and hire key personnel, or its operating results and business generally.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
DEFA14A
CERE
Cerevel Therapeutics Holdings Inc
9 Feb 24
Additional proxy soliciting materials
9:00am
or other expenses; (vi) the effect of the announcement or pendency of the proposed Merger on Cerevel’s ability to retain and hire key personnel
DEFM14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Proxy related to merger
7:44am
) hire, promote or otherwise enter into any employment or consulting agreement or offer letter with, any employee, officer, director or other … to the provision of de minimis and non-recurring fringe benefits, (D) hire, promote, or otherwise enter into any employment or consulting agreement or offer
PRER14A
e83x10l27k
18 Jan 24
Preliminary revised proxy
7:19am
PREM14A
c12 wfbz57x66
5 Jan 24
Preliminary proxy related to merger
5:13pm
DEFA14A
opp4aybc8ejeiov4uj
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
EX-99.2
38yckano
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
g7yu5rb fcsfr
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-2.1
oxqqwp 46d5
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am